Marcus Quinkler wetenschapper
Quinkler, Marcus 1968-
VIAF ID: 35285656 (Personal)
Permalink: http://viaf.org/viaf/35285656
Preferred Forms
- 100 0 _ ‡a Marcus Quinkler ‡c wetenschapper
- 100 1 _ ‡a Quinkler, Marcus ‡d 1968-
- 100 1 _ ‡a Quinkler, Marcus ‡d 1968-
4xx's: Alternate Name Forms (3)
Works
Title | Sources |
---|---|
Einflüsse durch ACTH und Steroide auf die menschliche renale [11 beta-Hydroxysteroid-Dehydrogenase] und die Charakterisierung der Isoenzyme der 11β-Hydroxysteroid-Dehydrogenase [11 beta-Hydroxysteroid-Dehydrogenase] in Leber und Niere des Meerschweinchens | |
Impaired subjective health status in chronic adrenal insufficiency: impact of different glucocorticoid replacement regimens | |
Improved survival in patients with stage II adrenocortical carcinoma followed up prospectively by specialized centers | |
Improvement of health-related quality of life in adult women with 21-hydroxylase deficiency over a seven-year period. | |
In the search for specific inhibitors of human 11beta-hydroxysteroid-dehydrogenases (11beta-HSDs): chenodeoxycholic acid selectively inhibits 11beta-HSD-I | |
Increased expression of mineralocorticoid effector mechanisms in kidney biopsies of patients with heavy proteinuria | |
Is there sufficient evidence to consider the use of 11β-hydroxysteroid dehydrogenase type 1 inhibition in children? | |
Krebs cycle metabolite profiling for identification and stratification of pheochromocytomas/paragangliomas due to succinate dehydrogenase deficiency | |
Lack of influence of somatic mutations on steroid gradients during adrenal vein sampling in aldosterone-producing adenoma patients | |
Less common genotype variants of TP53 polymorphisms are associated with poor outcome in adult patients with adrenocortical carcinoma | |
Life-threatening events in patients with pheochromocytoma. | |
Long-term management in five cases of TSH-secreting pituitary adenomas: a single center study and review of the literature | |
Medical Therapy of Acromegaly in Germany 2019 - Data from the German Acromegaly Registry | |
The metabolic phenotype of patients with primary aldosteronism: impact of subtype and sex – a multicenter-study of 3566 Caucasian and Asian subjects | |
Metabolismus und Synthese von Steroidhormonen in der Niere und ihr Einfluss auf den Blutdruck | |
Mineralocorticoid substitution and monitoring in primary adrenal insufficiency | |
Mitotane Therapy in Adrenocortical Cancer Induces CYP3A4 and Inhibits 5α-Reductase, Explaining the Need for Personalized Glucocorticoid and Androgen Replacement | |
Mortality data from the European Adrenal Insufficiency Registry-Patient characterization and associations. | |
National German Audit of Diagnosis, Treatment, and Teaching in Secondary Adrenal Insufficiency. | |
Novel PHEX nonsense mutation in a patient with X-linked hypophosphatemic rickets and review of current therapeutic regimens. | |
Novel somatic mutations in the catalytic subunit of the protein kinase A as a cause of adrenal Cushing's syndrome: a European multicentric study | |
Observational study mortality in treated primary aldosteronism: the German Conn's registry. | |
OR29-2 Mild Autonomous Cortisol Excess (MACE) in Adrenal Incidentalomas - Metabolic Risk Profile and Urinary Steroid Metabolome Analysis in 1208 Prospectively Recruited Patients | |
Persistence of myopathy in Cushing's syndrome: evaluation of the German Cushing's Registry. | |
[Pheochromocytoma: current diagnostics and treatment]. | |
Post-saline infusion test aldosterone levels indicate severity and outcome in primary aldosteronism | |
Prednisolone is associated with a worse lipid profile than hydrocortisone in patients with adrenal insufficiency. | |
Pregnancy in Women Previously Treated for an Adrenocortical Carcinoma. | |
Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism. | |
Primary Aldosteronism: Key Characteristics at Diagnosis - a Trend towards Milder Forms. | |
The Primary Aldosteronism Surgical Outcome Score for the Prediction of Clinical Outcomes After Adrenalectomy for Unilateral Primary Aldosteronism | |
[Primary hyperaldosteronism--more common than previously thought]. | |
Primary hyperparathyroidism | |
Progesterone is extensively metabolized in osteoblasts: implications for progesterone action on bone. | |
Prolonged zona glomerulosa insufficiency causing hyperkalemia in primary aldosteronism after adrenalectomy | |
Radiation Exposure of Adrenal Vein Sampling - a German Multicenter Study | |
Reduced 11beta-hydroxysteroid dehydrogenase type 1 activity in obese boys. | |
Reduction in daily hydrocortisone dose improves bone health in primary adrenal insufficiency | |
Reduction of the vitamin D hormonal system in kidney disease is associated with increased renal inflammation | |
Renal TLR4 mRNA expression correlates with inflammatory marker MCP-1 and profibrotic molecule TGF-β₁ in patients with chronic kidney disease. | |
Reply | |
Response Letter to the Editor from Sweeney AT: "CT Characteristics of Pheochromocytoma: Relevance for the Evaluation of Adrenal Incidentaloma" | |
Risk factors associated with a low glomerular filtration rate in primary aldosteronism | |
The role of capillary density, macrophage infiltration and interstitial scarring in the pathogenesis of human chronic kidney disease | |
The role of surgery in the management of recurrent adrenocortical carcinoma | |
Safety of medical adjustment and confirmatory testing in the diagnostic work-up of primary aldosteronism | |
Saving lives of patients with adrenal insufficiency: a pan-European initiative? | |
Sex steroid metabolism in human peripheral blood mononuclear cells changes with aging | |
Sexuality in Males With Congenital Adrenal Hyperplasia Resulting From 21-Hydroxylase Deficiency | |
Side population does not define stem cell-like cancer cells in the adrenocortical carcinoma cell line NCI h295R. | |
Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension | |
Steroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronism | |
Subtyping of Primary Aldosteronism in the AVIS-2 Study: Assessment of Selectivity and Lateralization | |
Successful Asfotase Alfa Treatment in an Adult Dialysis Patient With Childhood-Onset Hypophosphatasia. | |
Sunitinib in Refractory Adrenocortical Carcinoma: A Phase II, Single-Arm, Open-Label Trial | |
[Surgical strategies for non-metastatic adrenocortical carcinoma]. | |
Surgical therapy of adrenal tumors: guidelines from the German Association of Endocrine Surgeons (CAEK) | |
Targeting CXCR4 (CXC Chemokine Receptor Type 4) for Molecular Imaging of Aldosterone-Producing Adenoma. | |
Testosterone and blood pressure regulation | |
Therapy of endocrine disease: Perspectives on the management of adrenal insufficiency: clinical insights from across Europe. | |
Timelines in the management of adrenal crisis - targets, limits and reality | |
Total adrenal volume but not testicular adrenal rest tumor volume is associated with hormonal control in patients with 21-hydroxylase deficiency | |
Treatment of advanced adrenocortical carcinoma with erlotinib plus gemcitabine | |
Treatment of Refractory Adrenocortical Carcinoma with Thalidomide: Analysis of 27 Patients from the European Network for the Study of Adrenal Tumours Registry | |
Tumor size of Conn's adenoma and comorbidities. | |
Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study | |
Value of Molecular Classification for Prognostic Assessment of Adrenocortical Carcinoma | |
What is the best long-term management strategy for patients with primary adrenal insufficiency? | |
Worsening of lipid metabolism after successful treatment of primary aldosteronism | |
প্রত্যুত্তর |